Each month FDA will update a publically available list of drugs designated as orphan drugs. A cumulative, updated list of all designated drugs will be provided annually. These will be placed on file at the FDA Division of Dockets Management, and will contain the following information:
(a)
The name and address of the manufacturer and sponsor;
(b)
The generic name and trade name, if any, of the drug and the date of the granting of orphan-drug designation;
(c)
The rare disease or condition for which orphan-drug designation was granted; and
(d)
The proposed indication for use of the drug.